1. Home
  2. DTIL vs FAAS Comparison

DTIL vs FAAS Comparison

Compare DTIL & FAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTIL
  • FAAS
  • Stock Information
  • Founded
  • DTIL 2006
  • FAAS 2021
  • Country
  • DTIL United States
  • FAAS Indonesia
  • Employees
  • DTIL N/A
  • FAAS N/A
  • Industry
  • DTIL Biotechnology: Pharmaceutical Preparations
  • FAAS
  • Sector
  • DTIL Health Care
  • FAAS
  • Exchange
  • DTIL Nasdaq
  • FAAS NYSE
  • Market Cap
  • DTIL 51.6M
  • FAAS 48.2M
  • IPO Year
  • DTIL 2019
  • FAAS N/A
  • Fundamental
  • Price
  • DTIL $4.79
  • FAAS $0.57
  • Analyst Decision
  • DTIL Strong Buy
  • FAAS
  • Analyst Count
  • DTIL 2
  • FAAS 0
  • Target Price
  • DTIL $47.00
  • FAAS N/A
  • AVG Volume (30 Days)
  • DTIL 85.2K
  • FAAS 20.3M
  • Earning Date
  • DTIL 07-31-2025
  • FAAS 01-01-0001
  • Dividend Yield
  • DTIL N/A
  • FAAS N/A
  • EPS Growth
  • DTIL N/A
  • FAAS N/A
  • EPS
  • DTIL N/A
  • FAAS N/A
  • Revenue
  • DTIL $51,141,000.00
  • FAAS $57,730,593.00
  • Revenue This Year
  • DTIL N/A
  • FAAS N/A
  • Revenue Next Year
  • DTIL $30.20
  • FAAS N/A
  • P/E Ratio
  • DTIL N/A
  • FAAS N/A
  • Revenue Growth
  • DTIL N/A
  • FAAS 38.16
  • 52 Week Low
  • DTIL $3.61
  • FAAS $0.16
  • 52 Week High
  • DTIL $11.09
  • FAAS $8.49
  • Technical
  • Relative Strength Index (RSI)
  • DTIL 44.86
  • FAAS 48.67
  • Support Level
  • DTIL $4.20
  • FAAS $0.57
  • Resistance Level
  • DTIL $5.29
  • FAAS $0.69
  • Average True Range (ATR)
  • DTIL 0.36
  • FAAS 0.18
  • MACD
  • DTIL -0.03
  • FAAS -0.04
  • Stochastic Oscillator
  • DTIL 36.88
  • FAAS 9.73

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

About FAAS DIGIASIA CORP

DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.

Share on Social Networks: